Dartisla Odt Drug Interactions: 56 Major, 47 Moderate
Dartisla Odt (Glycopyrrolate Orally Disintegrating Tablets) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dartisla Odt. Always confirm against the full prescribing information.
100 interactions
Alfentanil
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Alfentanil.
Level 1 evidence
Amantadine
Amantadine may increase the anticholinergic activities of Glycopyrronium.
Level 1 evidence
Atenolol
The bioavailability of Atenolol can be increased when combined with Glycopyrronium.
Level 2 evidence
Benzhydrocodone
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Benzhydrocodone.
Level 1 evidence
Botulinum toxin type A
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum toxin type A.
Level 1 evidence
Botulinum toxin type B
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum toxin type B.
Level 2 evidence
Buprenorphine
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Buprenorphine.
Level 1 evidence
Butorphanol
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Butorphanol.
Level 1 evidence
Cannabidiol
The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Cannabidiol.
Level 2 evidence
Clomipramine
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Clomipramine.
Level 2 evidence
Codeine
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Codeine.
Level 1 evidence
Dextropropoxyphene
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Dextropropoxyphene.
Level 1 evidence
Enter your NPI to unlock 25 major interactions for Dartisla Odt
Dartisla Odt (Glycopyrrolate Orally Disintegrating Tablets) has 254 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Dartisla Odt (Glycopyrrolate Orally Disintegrating Tablets) has 56 major, 47 moderate, and 151 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dartisla Odt. Always confirm against the full prescribing information.